Liang Xu

12PUBLICATIONS
43CO-AUTHORS
Respiratory diseasesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 14, 2025
HuR inhibition reduces post-ischemic cardiac remodeling by dampening myocyte-dependent inflammatory gene expression and the innate immune response.

Samuel Slone, Sarah R Anthony, Lisa C Green

|Dec 03, 2024
RNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer.

Lanjing Wei, Sung Hae Kim, Ahlam M Armaly

|Oct 18, 2023
Niclosamide improves cancer immunotherapy by modulating RNA-binding protein HuR-mediated PD-L1 signaling.

Qi Zhang, Zhe Yang, Xinbao Hao

|Jul 29, 2023
Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147.

Zhe Yang, Qi Zhang, Xiaoqing Wu

|Jun 26, 2023
Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy.

Lanjing Wei, Qi Zhang, Cuncong Zhong

|Jan 30, 2023
Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry.

Nan Bai, Yusuf Adeshina, Igor Bychkov

Pageof 2

Frequent Collaborators

5 joint publications

Xiaoqing Wu

3 joint publications

Lan Lan

3 joint publications

John Karanicolas

2 joint publications

Gulhumay Gardashova